Outcomes of child psychiatric treatment

Acta Psychiatrica Scandinavica

Volumn 128, Issue 1, 2013, Pages 34-44

  Lundh, A ^a   Forsman, M ^b   Serlachius, E ^a,b   Lichtenstein, P ^a   Landen M ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Center for Psychiatric Research Norra Stationsgatan 69 7tr Stockholm   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adolescent; Child; Mental disorders therapy; Outcome assessment; Psychiatric status rating scales

Indexed keywords

CENTRAL STIMULANT AGENT;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CHILD; CHILD PSYCHIATRY; COGNITIVE THERAPY; COMMUNICATION DISORDER; CONDUCT DISORDER; DIAGNOSIS RELATED GROUP; DISSOCIATIVE DISORDER; EATING DISORDER; ENURESIS; FECES INCONTINENCE; FEMALE; FUNCTIONAL DISEASE; GENDER DYSPHORIA; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MENTAL HEALTH CARE; MOTOR DYSFUNCTION; OBSESSIVE COMPULSIVE DISORDER; OPPOSITIONAL DEFIANT DISORDER; OUTCOME VARIABLE; OUTPATIENT; OUTPATIENT CARE; PATIENT COUNSELING; POSTTRAUMATIC STRESS DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL DISORDER; PSYCHOTHERAPY; SCHIZOPHRENIA; SCHOOL CHILD; SLEEP DISORDER; SOCIAL NETWORK; SOCIAL PSYCHOLOGY; SOMATOFORM DISORDER; SPECIAL EDUCATION; SUICIDE ATTEMPT; SWEDEN; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; AMBULATORY CARE; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; CHILD; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; COMMUNITY MENTAL HEALTH CENTERS; COMORBIDITY; FEMALE; HUMANS; MALE; MOOD DISORDERS; SUICIDE, ATTEMPTED; SWEDEN;

EID: 84878925285     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12043     Document Type: Article

References (43)

1. Kendall T, Pilling S, Whittington C, Pettinari C, Burbeck R. Clinical Guidelines in Mental Health II: a guide to making NICE Guidelines. Psychiatr Bull 2005;29:3-8.
2. Fonagy P. Evaluating the effectiveness of interventions in child psychiatry. Can J Psychiatry 1997;42:584-594.
3. Stevens J, Kelleher K, Greenhouse J et al. Empirical evaluation of the generalizability of the sample from the multimodal treatment study for ADHD. Adm Policy Ment Health 2007;34:221-232.
4. Hoagwood K, Jensen PS, Petti T, Burns BJ. Outcomes of mental health care for children and adolescents: I. A comprehensive conceptual model. J Am Acad Child Adolesc Psychiatry 1996;35:1055-1063.
5. Weisz JR, Donenberg GR, Han SS, Weiss B. Bridging the gap between laboratory and clinic in child and adolescent psychotherapy. J Consult Clin Psychol 1995;63:688-701.
6. Hoagwood K, Hibbs E, Brent D, Jensen P. Introduction to the special section: efficacy and effectiveness in studies of child and adolescent psychotherapy. J Consult Clin Psychol 1995;63:683-687.
7. Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 2009;166:42-49.
8. Sourander A, Jensen P, Davies M et al. Who is at greatest risk of adverse long-term outcomes? The Finnish from a boy to a man study. J Am Acad Child Adolesc Psychiatry 2007;46:1148-1161.
9. Lambert MJ, Bergin AE, Garfield SL. Bergin and Garfield's handbook of psychotherapy and behavior change, 5th edn. New York: Wiley, 2004.
10. Kendall PC, Southam-Gerow MA. Issues in the transportability of treatment: the case of anxiety disorders in youths. J Consult Clin Psychol 1995;63:702-708.
11. Weisz JR, Donenberg GR, Han SS, Kauneckis D. Child and adolescent psychotherapy outcomes in experiments versus clinics: why the disparity? J Abnorm Child Psychol 1995;23:83-106.
12. Gilbody SM, House AO, Sheldon TA. Outcomes research in mental health. Systematic review. Br J Psychiatry 2002;181:8-16.
13. Ellwood PM. Shattuck lecture-outcomes management. A technology of patient experience. N Engl J Med 1988;318:1549-1556.
14. Stein BD, Kogan JN, Hutchison SL, Magee EA, Sorbero MJ. Use of outcomes information in child mental health treatment: results from a pilot study. Psychiatr Serv 2010;61:1211-1216.
15. Garland AF, Bickman L, Chorpita BF. Change what? Identifying quality improvement targets by investigating usual mental health care. Adm Policy Ment Health 2010;37:15-26.
16. Rapee RM, Bögels SM, Van Der Sluis CM, Craske MG, Ollendick T. Annual research review: conceptualising functional impairment in children and adolescents. J Child Psychol 2012;53:454-468.
17. Shaffer D, Gould MS, Brasic J et al. A children's global assessment scale (CGAS). Arch Gen Psychiatry 1983;40:1228-1231.
18. Gold J, Buonopane RJ, Caggiano RA et al. Assessing outcomes in child psychiatry. Am J Manag Care 2009;15:210-216.
19. Wolpert M, Cooper L, Tingay K, Young K, Svanberg E. CAMHS Outcomes Research Consortium (CORC) Version 2.0. Handbook London, UK, 2007. Available from: http://www.corc.uk.net/media/File/CORCResources/Handbook/HANDBOOK2007.pdf. cited 28 September 2012.
20. Garralda ME, Yates P, Higginson I. Child and adolescent mental health service use. HoNOSCA as an outcome measure. Br J Psychiatry 2000;177:52-58.
21. Steinhausen HC, Metzke CW. Global measures of impairment in children and adolescents: results from a Swiss community survey. Aust N Z J Psychiatry 2001;35:282-286.
22. Kratochvil CJ, Vaughan BS, Mayfield-Jorgensen ML et al. A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17:175-185.
23. Vitiello B, Rohde P, Silva S et al. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006;45:1419-1426.
24. Brent DA, Holder D, Kolko D et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 1997;54:877-885.
25. Hanssen-Bauer K, Aalen OO, Ruud T, Heyerdahl S. Inter-rater reliability of clinician-rated outcome measures in child and adolescent mental health services. Adm Policy Ment Health 2007;34:504-512.
26. Lundh A, Kowalski J, Sundberg CJ, Gumpert C, Landén M. Children's Global Assessment Scale (CGAS) in a naturalistic clinical setting: Inter-rater reliability and comparison with expert ratings. Psychiatry Res 2010;177:206-210.
27. Lundh A, Kowalski J, Sundberg CJ, Landén M. A comparison of seminar and computer based training on the accuracy and reliability of raters using the Children's Global Assessment Scale (CGAS). Adm Policy Ment Health 2012;39:458-465.
28. Shrout PE. Measurement reliability and agreement in psychiatry. Stat Methods Med Res 1998;7:301-317.
29. March J, Silva S, Petrycki S et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004;292:807-820.
30. Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 2006;45:280-288.
31. Findling RL, Short EJ, Leskovec T et al. Aripiprazole in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2008;18:347-354.
32. Berek M, Kordon A, Hargarter L et al. Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS(R) MPH: is treatment response different between children and adolescents? Child Adolesc Psychiatry Ment Health 2011;5:26.
33. Steinhausen HC, Novik TS, Baldursson G et al. Co-existing psychiatric problems in ADHD in the ADORE cohort. Eur Child Adolesc Psychiatry 2006;15(Suppl 1):I25-I29.
34. Preuss U, Ralston SJ, Baldursson G et al. Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study. Eur Child Adolesc Psychiatry 2006;15(Suppl 1):I4-I14.
35. Szobot CM, Ketzer C, Parente MA, Biederman J, Rohde LA. The acute effect of methylphenidate in Brazilian male children and adolescents with ADHD: a randomized clinical trial. J Atten Disord 2004;8:37-43.
36. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999;56:1073-1086.
37. Steinhausen HC. The heterogeneity of causes and courses of attention-deficit/hyperactivity disorder. Acta Psychiatr Scand 2009;120:392-399.
38. Zoëga H, Furu K, Halldorsson M, Thomsen PH, Sourander A, Martikainen JE. Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 2011;123:360-367.
39. Molina BS, Hinshaw SP, Swanson JM et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 2009;48:484-500.
40. National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults, 2008. Available from: http://www.nice.org.uk/CG72. cited 28 September 2012.
41. Henggeler SW, Schoenwald SK, Pickrel SG. Multisystemic therapy: bridging the gap between university- and community-based treatment. J Consult Clin Psychol 1995;63:709-717.
42. Pediatric OCD Treatment Study (POTS). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004;292:1969-1976.
43. Franklin ME, Sapyta J, Freeman JB et al. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA 2011;306:1224-1232.